115
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Association between glomerular filtration rate and extracellular fluid volume in normal subjects and patients with renal impairment

, , &
Pages 39-49 | Received 26 Jan 2007, Accepted 10 May 2007, Published online: 08 Jul 2009
 

Abstract

The aim of the study was to determine the extent to which glomerular filtration rate (GFR) measured with one filtration marker is associated with extracellular fluid volume (ECV) measured independently with another. Cr‐51‐EDTA and iohexol were injected simultaneously into opposite arms in 20 normal volunteers and 60 patients. Cubital samples taken bilaterally at 20, 40, 60, 120, 180 and 240 min were assayed for marker injected contralaterally. GFR was scaled to body surface area of 1.73 m2 (GFR/BSA). GFR was also expressed as marker transit time (GFR/ECV) and ECV as the product of marker transit time and GFR/BSA. In normal subjects, changes between fasting and non‐fasting ECV/BSA correlated positively with changes in GFR/BSA, but not GFR/ECV. GFR/BSA and GFR/ECV correlated positively (regression slope ∼4 ml.min−1.litre−1) and negatively (−2.7 ml.min−1.litre−1), respectively, with ECV/BSA. The difference, 6.7 ml.min−1.litre−1, expressed as a fraction of average scaled GFR (∼90 ml.min−1) is close to the reciprocal of average ECV/BSA (13.5 litres.1.73 m−2), consistent with the expected slope of the regression on ECV/BSA of the difference‐to‐average ratio of GFR/BSA and GFR/ECV. In contrast, in 29 patients with impaired GFR (estimated from plasma creatinine), ECV/BSA correlated inversely with GFR/ECV (slope ∼−5 ml.min−1.litre−1) but showed no relation with GFR/BSA. We conclude that in normal subjects GFR/BSA increases in response to increasing ECV/BSA, but the increase is not proportionate, leading to a weak inverse association between GFR/ECV and ECV/BSA. When ECV is expanded in patients with renal impairment, however, there is no GFR response, leading to a reduction in GFR/ECV.

Acknowledgement

This work was supported by the National Kidney Research Fund.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.